Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the impact of a social media campaign and community engagement activities to promote pre-exposure prophylaxis (PrEP) use among young women and to influence com...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Collaborators
NCT06694805 · HIV Infections
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT07071623 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
NCT04142047 · HIV, HIV Infections
NCT07221747 · Oral Pre-exposure Prophylaxis (PrEP), Long-acting Injectable Cabotegravir for PrEP
TB HIV Care
Cape Town, Western Cape
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions